X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ALEMBIC PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ALEMBIC PHARMA STERLING BIOTECH/
ALEMBIC PHARMA
 
P/E (TTM) x -1.7 29.5 - View Chart
P/BV x 0.1 6.7 1.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 STERLING BIOTECH   ALEMBIC PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ALEMBIC PHARMA
Mar-16
STERLING BIOTECH/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs11792 1.3%   
Low Rs3443 0.8%   
Sales per share (Unadj.) Rs26.8167.0 16.0%  
Earnings per share (Unadj.) Rs-15.038.2 -39.2%  
Cash flow per share (Unadj.) Rs-5.542.0 -13.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs54.984.9 64.6%  
Shares outstanding (eoy) m267.87188.52 142.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.7 7.0%   
Avg P/E ratio x-0.516.2 -2.9%  
P/CF ratio (eoy) x-1.314.7 -8.7%  
Price / Book Value ratio x0.17.3 1.7%  
Dividend payout %010.5 0.0%   
Avg Mkt Cap Rs m1,862116,383 1.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5474,214 13.0%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18131,487 22.8%  
Other income Rs m4355 77.3%   
Total revenues Rs m7,22331,542 22.9%   
Gross profit Rs m94710,060 9.4%  
Depreciation Rs m2,543722 352.2%   
Interest Rs m4,37737 11,894.3%   
Profit before tax Rs m-5,9319,356 -63.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,160 -89.1%   
Profit after tax Rs m-4,0077,194 -55.7%  
Gross profit margin %13.231.9 41.3%  
Effective tax rate %32.423.1 140.5%   
Net profit margin %-55.822.8 -244.2%  
BALANCE SHEET DATA
Current assets Rs m14,33515,066 95.1%   
Current liabilities Rs m49,8097,674 649.0%   
Net working cap to sales %-494.023.5 -2,104.5%  
Current ratio x0.32.0 14.7%  
Inventory Days Days40367 602.4%  
Debtors Days Days17141 420.0%  
Net fixed assets Rs m55,4328,237 672.9%   
Share capital Rs m268377 71.1%   
"Free" reserves Rs m13,93515,416 90.4%   
Net worth Rs m14,70116,005 91.9%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98824,594 300.8%  
Interest coverage x-0.4255.2 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.3 7.6%   
Return on assets %0.529.4 1.7%  
Return on equity %-27.344.9 -60.6%  
Return on capital %-6.458.7 -11.0%  
Exports to sales %25.955.7 46.5%   
Imports to sales %0.210.4 1.6%   
Exports (fob) Rs m1,86017,551 10.6%   
Imports (cif) Rs m123,283 0.4%   
Fx inflow Rs m1,86017,811 10.4%   
Fx outflow Rs m255,318 0.5%   
Net fx Rs m1,83512,493 14.7%   
CASH FLOW
From Operations Rs m1,7199,304 18.5%  
From Investments Rs m-3,148-3,105 101.4%  
From Financial Activity Rs m1,426-1,959 -72.8%  
Net Cashflow Rs m-34,240 -0.1%  

Share Holding

Indian Promoters % 33.9 74.1 45.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 9.9 9.1 108.8%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 13.9 282.7%  
Shareholders   21,482 49,328 43.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   SHASUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  MERCK LTD  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 20, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - WYETH LTD COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS